Professional Documents
Culture Documents
3/29/13
Introduction
The Indian Pharmaceutical Industry is a success story of providing employment for the millions and ensuring that essential drug at affordable prices are available to the vast population of Indian sub continent. The Indian Pharmaceutical Industry is the developing worlds largest and most developed, raking 4th in the world in terms of production value and 13th in domestic consumption value. India has considerable manufacturing Expertise , Indian companies are among the world leaders in the production of Generics & Vaccines Healthcare has become one of the key priorities of the Key Government & it has launched new policies & Programs to boost local Access & affordability to quality healthcare
3/29/13
3/29/13
Six Trends will influence the Growth of Indian Pharma Market/ DEMAND DRIVERs
Growing & Aging, Sick Population 2) Rapid Growth in Several Chronic Disease 3) Doubling of Disposable Income & the number of Middle class household 4) Penetration in Rural market & Tier 2 Cities 5) 10% of the Indian Market is Likely to be Patent Protected by 2015 6) Expansion of Medical Infrastructure by Government/ Policy maker
1)
3/29/13
No of people in India suffering from this disease is set to double by 2020 v India has a Largest Pool of Diabetic Patient, more than 41 Million People Suffering vIndia is Home of Diabetic Population : Patient 73.5 Million in 2025 & Total bill of treating them would be about US$ 30 Billion by 2025 3/29/13
v
In India 8% Global drugs market by Volume & only 1% by Value but due the rapidly increasing purchasing power of Indian Consumers India could improve it s Price Volume Mix
v
This change in Patient demographics will fuel the demand & which will change the Pattern of Demand
v
3/29/13
3/29/13
3/29/13
Patent Cliff
Generics Products will continue to dominate the Indian Market Next few years there will be launch of Patent Protected products which will capture the 10% share of total market by 2015 During year 2010 0-2015 30 to 40 new molecule will be launch globally every year & 75% of these will be introduced in the in the Indian market Around US$ 25 billion worth of Biologics are expected to go off Patent by 2016 this will open route for equivalent generics & enhance the Indian Pharma sector to grow Patented Products are in 5 therapeutic areas : Oncology, Anti infective GastroIntestinal, Neuropsychiatry & Cardiovascular By 2015 this 5 therapies to contribute 60-70 % of total Patented product launch
3/29/13
3/29/13
CONCLUSION
India will see the largest number of merger and acquisitions (M&As) in the pharmaceutical and healthcare sector The Ministry of Commerce has proposed an ambitious Strategy Plan to double pharmaceutical exports from US$ 10.4 billion in 2009-10 to US$ 25 billion by 2013-14. Gujarat-based small and medium-sized pharmaceutical manufacturers are focusing on export markets, especially to emerging economies such as African and Latin American nations. Small and medium sized enterprises (SMEs) based in Gujarat exported pharma products worth Rs 400-Rs 500 crore (US$ 74.63-US$ 93.28 million) in 2011-12. Of the net exports by SMEs, the share of emerging markets is 50-60 per cent, and it is rising yearly by 30-35 per cent, as per an Indian Drug Manufacturers' Association (IDMA) official
3/29/13
2)
3) 4)
Report of Task Force, Ministry of Commerce & Industry Analysis of the Indian Pharmaceutical Industry Pricewaterhousecoopers Google
3/29/13
THANK YOU
3/29/13